Skip to main content
OpenTrials

Clinical trial condition

Sexual Dysfunctions, Psychological

Explore clinical trials studying Sexual Dysfunctions, Psychological. Study availability and eligibility vary by location and protocol.

111 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Sexual Dysfunctions, Psychological trial results

Completed

Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder

NCT00601367

Conditions
Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • 511.118.43005 Boehringer Ingelheim Investigational Site Innsbruck, Austria
  • 511.118.43002 Boehringer Ingelheim Investigational Site Vienna, Austria
  • 511.118.43004 Boehringer Ingelheim Investigational Site Vienna, Austria
  • 511.118.43006 Boehringer Ingelheim Investigational Site Wörgl, Austria
View all 68 locations
View Trial Details
Completed

Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

NCT00996372

Conditions
Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • 511.130.01074 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 511.130.01046 Boehringer Ingelheim Investigational Site Huntsville, Alabama, United States
  • 511.130.01042 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 511.130.01025 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
View all 75 locations
View Trial Details
Completed

Flibanserin Versus Placebo in Premenopausal Women With HSDD

NCT00491829

Conditions
Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • 511.77.43005 Boehringer Ingelheim Investigational Site Innsbruck, Austria
  • 511.77.43001 Boehringer Ingelheim Investigational Site Vienna, Austria
  • 511.77.43002 Boehringer Ingelheim Investigational Site Vienna, Austria
  • 511.77.43004 Boehringer Ingelheim Investigational Site Vienna, Austria
View all 86 locations
View Trial Details
Completed

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

NCT01188603

Conditions
Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • 511.146.01003 Boehringer Ingelheim Investigational Site Orlando, Florida, United States
  • 511.146.01005 Boehringer Ingelheim Investigational Site Wichita, Kansas, United States
  • 511.146.01001 Boehringer Ingelheim Investigational Site Kalamazoo, Michigan, United States
  • 511.146.01004 Boehringer Ingelheim Investigational Site Knoxville, Tennessee, United States
View Trial Details
Completed

Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

NCT00996164

Conditions
Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • 511.147.01074 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 511.147.01046 Boehringer Ingelheim Investigational Site Huntsville, Alabama, United States
  • 511.147.01042 Boehringer Ingelheim Investigational Site Mobile, Alabama, United States
  • 511.147.01025 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
View all 75 locations
View Trial Details
Completed

Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems

NCT01743235

Conditions
Hypoactive Sexual Desire Disorder, Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • San Diego Sexual Medicine San Diego, California, United States
  • Meridien Research Bradenton, Florida, United States
  • Segal Insitute for Clinical Research North Miami, Florida, United States
  • Compass Research Orlando, Florida, United States
View Trial Details
Completed

Lybrido for Female Sexual Dysfunction

NCT01432665

Conditions
Hypoactive Sexual Desire Disorder, Mental Disorders, Sexual Dysfunctions, Psychological
Locations
  • San Diego Sexual Medicine San Diego, California, United States
  • The Center for Vulvovaginal Disorders Washington D.C., District of Columbia, United States
  • Meridien Research Brooksville, Florida, United States
  • Segal Institute Women's Health Clinic North Miami, Florida, United States
View all 14 locations
View Trial Details

Related conditions